The Latin American DILI Registry Experience: A Successful Ongoing Collaborative Strategic Initiative

Drug induced liver injury (DILI) is a rare but well recognized serious adverse reaction. Pre-marketing studies may not detect liver injury, and DILI becomes very often apparent after the drug is launched to the market. Specific biomarkers for DILI prediction or diagnosis are not available. Toxic liv...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessone, Fernando, Hernandez, Nelia, Lucena, M. Isabel, Andrade, Raúl J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813176/
https://www.ncbi.nlm.nih.gov/pubmed/26938524
http://dx.doi.org/10.3390/ijms17030313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813176/
https://www.ncbi.nlm.nih.gov/pubmed/26938524
http://dx.doi.org/10.3390/ijms17030313

Ejemplares similares